This research demonstrates effective imaging of gamma rays in cancer treatment, suggesting improved boron neutron capture therapy monitoring.
The accurate imaging and quantitative measurement of 478-keV prompt gamma rays are critical for advancing boron neutron capture therapy (BNCT), a promising cancer treatment. Although numerical simulations have indicated that such measurements are feasible, their practical application has proven challenging. This study introduces a gamma-ray imaging detector designed specifically for precise BNCT measurements. Using boron-rich phantom samples, we successfully imaged 478-keV gamma rays and established a linear correlation between gamma-ray production and boron concentration. Furthermore, applying this technique in a recognized BNCT treatment facility demonstrated the detector’s effectiveness in monitoring boron dose distribution during neutron irradiation, both in pre-treatment diagnostics and throughout the treatment process.
No takes yet. Share an insight, caveat, or question.
Mizumoto et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: